HYUNDAI BIOSCIENCE CO., LTD.

Other languages Hyundai Bioscience Co., Ltd.

Equities

A048410

KR7048410005

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
18,370 ^KRW	+0.66%		+4.20%	-29.62%

17/06	Hyundai Bioscience Co., Ltd. announced that it expects to receive KRW 3 billion in funding	CI
20/05	Hyundai Bioscience Co., Ltd., CnPharm Co., Ltd. and Yeonjin Kim completed the acquisition of 34.91% stake in ADM Korea Inc. from Mobiis Co., Ltd..	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Hyundai Bioscience Co., Ltd., CnPharm Co., Ltd. and Yeonjin Kim completed the acquisition of 34.91% stake in ADM Korea Inc. from Mobiis Co., Ltd..	20/05
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Hyundai Bioscience's Antiviral for Dengue Fever to Enter Clinical Trials in Brazil	25/04
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-Based Metabolic Anticancer Drug Targeting P53 Mutation Cancer	25/04
Hyundai Bioscience Announces Its Successful Result from A Preclinical Study of A Niclosamide-Based Oral Anticancer Drug to Treat Triple-Negative Breast Cancer	22/04
Hyundai Bioscience to Carry Out Global Clinical Tests Aimed At Treating All Serotypes of Dengue Virus Infection	19/04
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Vector Inc. completed the acquisition of additional 25.071429% stake in Vitabrid Japan Inc. from Hyundai Bioscience Co., Ltd.	31/23/31
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14
Hyundai Bioscience to request a fast track processing for its monkeypox treatment drug with the FDA	26/22/26
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16
Hyundai Bioscience Co., Ltd. Launches CP-COV03 Phase 2 Clinical Trials	12/22/12
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	21/22/21
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer